Zhu Y, Hendrix C, Busson R, Janssen G, Roets E, Hoogmartens J
Katholieke Universiteit Leuven, Laboratorium voor Farmaceutische Chemie, Instituut voor Farmaceutische Wetenschappen, Belgium.
J Pharm Biomed Anal. 1994 Sep;12(9):1137-40. doi: 10.1016/0731-7085(94)00042-5.
An impurity of unknown identity was isolated from commercial cefradine by liquid chromatography on poly (styrene-divinylbenzene) with HOAc (0.01 M)-CH3CN (94:6, v/v) as the mobile phase. The structure was elucidated as 4',5'-dihydrocefradine using nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS). The structure was confirmed by comparison with the chromatographic retention characteristics and photodiode-array detected ultraviolet spectrum of the synthetic compound and with its infrared, NMR and MS spectra. The presence of 4',5'-dihydrocefradine in cefradine has not been described previously.
采用聚(苯乙烯-二乙烯基苯)液相色谱法,以醋酸(0.01 M)-乙腈(94:6,v/v)为流动相,从市售头孢拉定中分离出一种身份不明的杂质。通过核磁共振光谱(NMR)和质谱(MS)确定其结构为4',5'-二氢头孢拉定。通过与合成化合物的色谱保留特性、光电二极管阵列检测的紫外光谱及其红外、NMR和MS光谱进行比较,证实了该结构。头孢拉定中4',5'-二氢头孢拉定的存在此前尚未见报道。